| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Collaboration revenue | $0-100.0% | $1.9M-90.5% | $19.9M+21.6% | $16.4M | $0 | — |
| Research and development | $44.8M-20.6% | $56.4M+35.1% | $41.8M-22.3% | $53.8M+52.4% | $35.3M+111.9% | $16.6M |
| General and administrative | $15.8M-16.8% | $19.0M+2.0% | $18.7M-0.1% | $18.7M+26.2% | $14.8M+157.1% | $5.8M |
| Total operating expenses | $60.7M-19.6% | $75.5M+24.9% | $60.4M-16.6% | $72.5M+44.7% | $50.1M+123.6% | $22.4M |
| Operating loss | -$60.7M+17.6% | -$73.6M-81.7% | -$40.5M+27.7% | -$56.1M-11.9% | -$50.1M-123.6% | -$22.4M |
| Interest income | $3.1M-53.4% | $6.7M-10.0% | $7.4M+288.7% | $1.9M+1734.6% | $104K | — |
| Interest expense | -$5.3M-13.3% | -$4.7M-48.3% | -$3.1M | $0 | — | — |
| Loss on extinguishment of debt | $0+100.0% | -$553K | $0 | — | — | — |
| Other income, net | $2.0M+25.1% | $1.6M+241.4% | -$1.1M-437.9% | $338K | $0 | — |
| Total other (expense) income | -$145K-104.7% | $3.1M-1.8% | $3.1M+39.6% | $2.2M+2059.6% | $104K-98.6% | $7.4M |
| Net loss | -$60.8M+13.7% | -$70.5M-88.7% | -$37.4M+30.6% | -$53.8M-7.7% | -$50.0M-232.3% | -$15.0M |
| Net loss per common share, basic (in usd per share) | -$1320.00+19.0% | -$1630.00-55.2% | -$1050.00+43.5% | -$1860.00+83.0% | -$10940.00+61.0% | -$28080.00 |
| Net loss per common share, diluted (in usd per share) | -$1330.00+18.4% | -$1630.00-55.2% | -$1050.00+43.5% | -$1860.00+83.0% | -$10940.00+61.0% | -$28080.00 |
| Weighted average common shares outstanding, basic (in shares) | 46.02B+6.2% | 43.33B+21.6% | 35.65B+23.5% | 28.86B+156301.7% | 18.5M+1736.3% | 1.0M |
| Weighted average common shares outstanding, diluted (in shares) | 46.81B+6.7% | 43.86B+23.0% | 35.65B+23.5% | 28.86B+156301.7% | 18.5M+1736.3% | 1.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.